Type II pneumocytes release chemoattractant activity for monocytes constitutively

Area of Science:

• Pulmonary Cell Biology
• Immunology
• Molecular Biology

Background:

• Type II pneumocytes play a role in lung immunity.
• Monocyte chemoattractant activity (MCA) is crucial for inflammatory responses.
• The constitutive release of chemoattractants by pneumocytes is not well understood.

Purpose of the Study:

• To investigate whether A549 cells, a type II pneumocyte cell line, constitutively release mediators responsible for monocyte chemoattractant activity (MCA).
• To characterize the nature and identify the specific mediators involved in MCA from A549 cell supernatant.

Main Methods:

• A549 cell supernatant fluids were assessed for monocyte chemotaxis using checkerboard analysis.
• Partial characterization of mediators involved lipid-soluble and trypsin-sensitive activities.
• Molecular sieve column chromatography, enzyme-linked immunosorbent assay (ELISA), and receptor antagonist assays were employed.

Main Results:

• A549 cell supernatant exhibited time-dependent MCA, primarily chemokinetic rather than chemotactic.
• Mediators were lipid-soluble, trypsin-sensitive, and included monocyte chemoattractant protein-1 (MCP-1) and transforming growth factor-beta (TGF-beta).
• Leukotriene B4 (LTB4) was identified as a significant chemoattractant, with its receptor antagonist attenuating the response.

Conclusions:

• Type II pneumocytes constitutively release MCP-1, TGF-beta, and LTB4.
• These released mediators modulate monocyte recruitment into the alveolar space.
• This constitutive release suggests a role for type II pneumocytes in maintaining alveolar immune homeostasis.